Cargando…
Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism
As a newly emerging metabolic regulator, accumulating evidence suggests that the circulating fibroblast growth factor 19 (FGF19) level correlated with lipid and glucose metabolism. Several independent groups have found that FGF19 was highly likely associated with multiple metabolic disorders. Thyroi...
Autores principales: | Lai, Yaxin, Wang, Haoyu, Xia, Xinghai, Wang, Zhaojun, Fan, Chenling, Wang, Hong, Zhang, Hongmei, Ding, Shuangning, Teng, Weiping, Shan, Zhongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265952/ https://www.ncbi.nlm.nih.gov/pubmed/27684859 http://dx.doi.org/10.1097/MD.0000000000005001 |
Ejemplares similares
-
Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism
por: Han, Cheng, et al.
Publicado: (2016) -
The correlation of lipid profile with subclinical and overt hypothyroidism: A cross-sectional study from Syria
por: Tarboush, Fatima, et al.
Publicado: (2023) -
The correlation between serum free thyroxine and regression of dyslipidemia in adult males: A 4.5-year prospective study
por: Wang, Haoyu, et al.
Publicado: (2017) -
Subclinical hypothyroidism increases insulin resistance in normoglycemic people
por: Yang, Wanyu, et al.
Publicado: (2023) -
Cardiovascular risk factors in children and adolescents with subclinical hypothyroidism: A protocol for meta-analysis and systematic review
por: DENG, Huan, et al.
Publicado: (2020)